Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Isabelle Henckaerts"'
Autor:
Pascale Van Belle, Pierre Vandepapelière, Yves Horsmans, Philippe Moris, Jeanne-Marie Devaster, Vincent Verlant, Jan Poolman, Philippe Hermand, Geert Leroux-Roels, Isabel Leroux-Roels, Isabelle Henckaerts
Publikováno v:
Vaccine. 33:577-584
BackgroundThe protection elicited by polysaccharide pneumococcal vaccines against community-acquired pneumonia in older adults remains debatable. Alternative vaccine targets include well-conserved pneumococcal protein antigens, such as pneumococcal h
Autor:
Jan Poolman, Isabelle Henckaerts, Carl E. Frasch, Shabir A. Madhi, Helena Käyhty, Pascal Lestrate
Publikováno v:
Clinical and Vaccine Immunology. 17:134-142
The history of the pneumococcal polysaccharide enzyme-linked immunosorbent assay (ELISA) is characterized by a continuous search for increased specificity. A third-generation ELISA that uses 22F polysaccharide inhibition has increased the specificity
Autor:
Birgit Simell, Isabelle Henckaerts, Jan Poolman, Petra Ahokas, Terhi Kilpi, Mika Lahdenkari, Helena Käyhty
Publikováno v:
Vaccine. 27:4615-4621
We assessed the development and role of serum anti-CbpA and -PhtD in early childhood in relation to pneumococcal exposure. Serum IgG concentrations to CbpA and PhtD were measured with enzyme immunoassay in serum samples collected at the ages of 6, 12
Autor:
Dominique Wauters, Isabelle Henckaerts, Anna Raitolehto, Helena Käyhty, Pascal Lestrate, Jan Poolman, Maija Toropainen
Publikováno v:
Infection and Immunity. 76:4546-4553
Unencapsulated, nontypeable Haemophilus influenzae (NTHI) is a frequent commensal of the human nasopharynx but is also the common cause of respiratory tract infections, such as otitis media (OM), sinusitis, bronchitis, and pneumonia (12, 22). Prevent
Publikováno v:
Vaccine. 25:2445-2450
During a randomised controlled trial with the 23-valent pneumococcal vaccine in older persons, antibody concentrations and opsonophagocytic activity (OPA) were compared between eight patients who developed culture-verified pneumococcal pneumonia and
Autor:
Pavla Kriz, Emmanuel Di-Paolo, Roman Prymula, Christiane Feron, Dominique Wauters, Lode Schuerman, Isabelle Henckaerts, Agnes Miseur, Jan Poolman
Publikováno v:
Vaccine. 27(24)
Background In contrast to the other vaccine serotypes, no protection could be demonstrated in the POET study against serotype 3 acute otitis media (AOM) following primary and booster vaccination with a multi-valent pneumococcal conjugate vaccine. Met
Publikováno v:
Vaccine. 25(13)
Immunological evaluation of the clinical impact of vaccines designed to protect against infection by Streptococcus pneumoniae requires measurement of serotype-specific functional antibodies. We describe the development and validation of a viable pneu
Publikováno v:
Vaccine. 25(11)
We explored the relationship between efficacy against acute otitis media (AOM) and both ELISA anti-polysaccharide IgG geometric mean concentrations (GMCs) and opsonophagocytic (OPA) geometric mean titres (GMTs) following primary and booster vaccinati
A comparative study was conducted between two laboratories in order to evaluate the differences between two enzyme-linked immunosorbent assay (ELISA) techniques for the detection of pneumococcal anti-capsular polysaccharide antibodies. One laboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d3465aa041a4ed103269bc9b264ebbf
https://europepmc.org/articles/PMC1391962/
https://europepmc.org/articles/PMC1391962/
Autor:
Terhi Kilpi, Jan Poolman, Isabelle Henckaerts, Jaana Joensuu, Pascal Peeters, Anu Nurkka, Helena Käyhty
Publikováno v:
The Pediatric infectious disease journal. 23(11)
Development is ongoing to increase the serotype coverage of pneumococcal conjugate vaccines. We report here the immunogenicity and safety of a new 11-valent pneumococcal conjugate vaccine (Pn-PD) in infants.In a randomized, single blind study, 154 Fi